nodes	percent_of_prediction	percent_of_DWPC	metapath
Fesoterodine—ABCB1—Ethinyl Estradiol—osteoporosis	0.0678	0.121	CbGbCtD
Fesoterodine—CYP3A4—Estropipate—osteoporosis	0.0631	0.113	CbGbCtD
Fesoterodine—CYP3A4—Calcitriol—osteoporosis	0.0631	0.113	CbGbCtD
Fesoterodine—CYP2D6—Cholecalciferol—osteoporosis	0.0511	0.0912	CbGbCtD
Fesoterodine—CYP3A4—Ergocalciferol—osteoporosis	0.0504	0.09	CbGbCtD
Fesoterodine—ABCB1—Conjugated Estrogens—osteoporosis	0.0498	0.0889	CbGbCtD
Fesoterodine—ABCB1—Estradiol—osteoporosis	0.0437	0.078	CbGbCtD
Fesoterodine—CYP3A4—Raloxifene—osteoporosis	0.0421	0.0751	CbGbCtD
Fesoterodine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0406	0.0726	CbGbCtD
Fesoterodine—CYP3A4—Cholecalciferol—osteoporosis	0.0325	0.058	CbGbCtD
Fesoterodine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0298	0.0533	CbGbCtD
Fesoterodine—CYP3A4—Estradiol—osteoporosis	0.0262	0.0468	CbGbCtD
Fesoterodine—Constipation—Alendronate—osteoporosis	0.000787	0.00198	CcSEcCtD
Fesoterodine—Angioedema—Pamidronate—osteoporosis	0.000786	0.00198	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000785	0.00198	CcSEcCtD
Fesoterodine—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.000783	0.00197	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000782	0.00197	CcSEcCtD
Fesoterodine—Somnolence—Calcitriol—osteoporosis	0.00078	0.00196	CcSEcCtD
Fesoterodine—Infestation NOS—Estradiol—osteoporosis	0.000775	0.00195	CcSEcCtD
Fesoterodine—Infestation—Estradiol—osteoporosis	0.000775	0.00195	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000774	0.00195	CcSEcCtD
Fesoterodine—Fatigue—Ibandronate—osteoporosis	0.000773	0.00194	CcSEcCtD
Fesoterodine—Chest pain—Risedronate—osteoporosis	0.00077	0.00194	CcSEcCtD
Fesoterodine—Dysgeusia—Zoledronate—osteoporosis	0.00077	0.00194	CcSEcCtD
Fesoterodine—Constipation—Ibandronate—osteoporosis	0.000766	0.00193	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000765	0.00193	CcSEcCtD
Fesoterodine—Pruritus—Etidronic acid—osteoporosis	0.000764	0.00192	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Estropipate—osteoporosis	0.000764	0.00192	CcSEcCtD
Fesoterodine—Mental disorder—Conjugated Estrogens—osteoporosis	0.000761	0.00192	CcSEcCtD
Fesoterodine—Back pain—Zoledronate—osteoporosis	0.00076	0.00191	CcSEcCtD
Fesoterodine—Feeling abnormal—Alendronate—osteoporosis	0.000759	0.00191	CcSEcCtD
Fesoterodine—Dry mouth—Risedronate—osteoporosis	0.000753	0.0019	CcSEcCtD
Fesoterodine—Urinary tract infection—Estradiol—osteoporosis	0.000753	0.0019	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Alendronate—osteoporosis	0.000753	0.00189	CcSEcCtD
Fesoterodine—Infection—Ethinyl Estradiol—osteoporosis	0.000753	0.00189	CcSEcCtD
Fesoterodine—Cough—Pamidronate—osteoporosis	0.000751	0.00189	CcSEcCtD
Fesoterodine—Constipation—Calcitriol—osteoporosis	0.00075	0.00189	CcSEcCtD
Fesoterodine—Flatulence—Conjugated Estrogens—osteoporosis	0.000746	0.00188	CcSEcCtD
Fesoterodine—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000743	0.00187	CcSEcCtD
Fesoterodine—Urticaria—Estropipate—osteoporosis	0.000742	0.00187	CcSEcCtD
Fesoterodine—Dysgeusia—Conjugated Estrogens—osteoporosis	0.000741	0.00186	CcSEcCtD
Fesoterodine—Vision blurred—Zoledronate—osteoporosis	0.000741	0.00186	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Raloxifene—osteoporosis	0.00074	0.00186	CcSEcCtD
Fesoterodine—Diarrhoea—Etidronic acid—osteoporosis	0.000739	0.00186	CcSEcCtD
Fesoterodine—Abdominal pain—Estropipate—osteoporosis	0.000739	0.00186	CcSEcCtD
Fesoterodine—Feeling abnormal—Ibandronate—osteoporosis	0.000739	0.00186	CcSEcCtD
Fesoterodine—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000736	0.00185	CcSEcCtD
Fesoterodine—Infection—Risedronate—osteoporosis	0.000734	0.00185	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Estradiol—osteoporosis	0.000733	0.00184	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Ibandronate—osteoporosis	0.000733	0.00184	CcSEcCtD
Fesoterodine—Back pain—Conjugated Estrogens—osteoporosis	0.000732	0.00184	CcSEcCtD
Fesoterodine—Urticaria—Alendronate—osteoporosis	0.000731	0.00184	CcSEcCtD
Fesoterodine—Abdominal pain—Alendronate—osteoporosis	0.000728	0.00183	CcSEcCtD
Fesoterodine—Nervous system disorder—Risedronate—osteoporosis	0.000724	0.00182	CcSEcCtD
Fesoterodine—Angioedema—Zoledronate—osteoporosis	0.000718	0.00181	CcSEcCtD
Fesoterodine—Skin disorder—Risedronate—osteoporosis	0.000717	0.00181	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Calcitriol—osteoporosis	0.000717	0.00181	CcSEcCtD
Fesoterodine—Abdominal pain—Raloxifene—osteoporosis	0.000716	0.0018	CcSEcCtD
Fesoterodine—Vision blurred—Conjugated Estrogens—osteoporosis	0.000713	0.00179	CcSEcCtD
Fesoterodine—Urticaria—Ibandronate—osteoporosis	0.000712	0.00179	CcSEcCtD
Fesoterodine—Abdominal pain—Ibandronate—osteoporosis	0.000708	0.00178	CcSEcCtD
Fesoterodine—Confusional state—Pamidronate—osteoporosis	0.000708	0.00178	CcSEcCtD
Fesoterodine—Vertigo—Zoledronate—osteoporosis	0.000706	0.00178	CcSEcCtD
Fesoterodine—Infection—Pamidronate—osteoporosis	0.000698	0.00176	CcSEcCtD
Fesoterodine—Urticaria—Calcitriol—osteoporosis	0.000697	0.00175	CcSEcCtD
Fesoterodine—Palpitations—Zoledronate—osteoporosis	0.000694	0.00175	CcSEcCtD
Fesoterodine—Abdominal pain—Calcitriol—osteoporosis	0.000694	0.00175	CcSEcCtD
Fesoterodine—Angioedema—Conjugated Estrogens—osteoporosis	0.000691	0.00174	CcSEcCtD
Fesoterodine—Hypersensitivity—Estropipate—osteoporosis	0.000689	0.00173	CcSEcCtD
Fesoterodine—Nervous system disorder—Pamidronate—osteoporosis	0.000689	0.00173	CcSEcCtD
Fesoterodine—Urinary tract disorder—Estradiol—osteoporosis	0.000687	0.00173	CcSEcCtD
Fesoterodine—Cough—Zoledronate—osteoporosis	0.000686	0.00173	CcSEcCtD
Fesoterodine—Oedema peripheral—Estradiol—osteoporosis	0.000685	0.00172	CcSEcCtD
Fesoterodine—Tachycardia—Pamidronate—osteoporosis	0.000685	0.00172	CcSEcCtD
Fesoterodine—Urethral disorder—Estradiol—osteoporosis	0.000682	0.00172	CcSEcCtD
Fesoterodine—Rash—Etidronic acid—osteoporosis	0.000681	0.00171	CcSEcCtD
Fesoterodine—Dermatitis—Etidronic acid—osteoporosis	0.00068	0.00171	CcSEcCtD
Fesoterodine—Vertigo—Conjugated Estrogens—osteoporosis	0.00068	0.00171	CcSEcCtD
Fesoterodine—Hypersensitivity—Alendronate—osteoporosis	0.000678	0.00171	CcSEcCtD
Fesoterodine—Headache—Etidronic acid—osteoporosis	0.000677	0.0017	CcSEcCtD
Fesoterodine—Asthenia—Estropipate—osteoporosis	0.000671	0.00169	CcSEcCtD
Fesoterodine—Chest pain—Zoledronate—osteoporosis	0.000669	0.00168	CcSEcCtD
Fesoterodine—Palpitations—Conjugated Estrogens—osteoporosis	0.000669	0.00168	CcSEcCtD
Fesoterodine—Insomnia—Risedronate—osteoporosis	0.000668	0.00168	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000664	0.00167	CcSEcCtD
Fesoterodine—Pruritus—Estropipate—osteoporosis	0.000661	0.00166	CcSEcCtD
Fesoterodine—Asthenia—Alendronate—osteoporosis	0.00066	0.00166	CcSEcCtD
Fesoterodine—Hypersensitivity—Ibandronate—osteoporosis	0.00066	0.00166	CcSEcCtD
Fesoterodine—Cough—Conjugated Estrogens—osteoporosis	0.00066	0.00166	CcSEcCtD
Fesoterodine—Dry mouth—Zoledronate—osteoporosis	0.000654	0.00165	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000654	0.00165	CcSEcCtD
Fesoterodine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000653	0.00164	CcSEcCtD
Fesoterodine—Pruritus—Alendronate—osteoporosis	0.000651	0.00164	CcSEcCtD
Fesoterodine—Dyspepsia—Risedronate—osteoporosis	0.00065	0.00164	CcSEcCtD
Fesoterodine—Eye disorder—Estradiol—osteoporosis	0.00065	0.00164	CcSEcCtD
Fesoterodine—Constipation—Ethinyl Estradiol—osteoporosis	0.000648	0.00163	CcSEcCtD
Fesoterodine—Confusional state—Zoledronate—osteoporosis	0.000647	0.00163	CcSEcCtD
Fesoterodine—Hypersensitivity—Calcitriol—osteoporosis	0.000646	0.00163	CcSEcCtD
Fesoterodine—Cardiac disorder—Estradiol—osteoporosis	0.000646	0.00162	CcSEcCtD
Fesoterodine—Chest pain—Conjugated Estrogens—osteoporosis	0.000644	0.00162	CcSEcCtD
Fesoterodine—Asthenia—Ibandronate—osteoporosis	0.000643	0.00162	CcSEcCtD
Fesoterodine—Nausea—Etidronic acid—osteoporosis	0.000642	0.00161	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00064	0.00161	CcSEcCtD
Fesoterodine—Diarrhoea—Estropipate—osteoporosis	0.000639	0.00161	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000638	0.0016	CcSEcCtD
Fesoterodine—Infection—Zoledronate—osteoporosis	0.000637	0.0016	CcSEcCtD
Fesoterodine—Fatigue—Risedronate—osteoporosis	0.000637	0.0016	CcSEcCtD
Fesoterodine—Insomnia—Pamidronate—osteoporosis	0.000635	0.0016	CcSEcCtD
Fesoterodine—Pruritus—Ibandronate—osteoporosis	0.000634	0.0016	CcSEcCtD
Fesoterodine—Constipation—Risedronate—osteoporosis	0.000632	0.00159	CcSEcCtD
Fesoterodine—Diarrhoea—Alendronate—osteoporosis	0.00063	0.00159	CcSEcCtD
Fesoterodine—Asthenia—Calcitriol—osteoporosis	0.000629	0.00158	CcSEcCtD
Fesoterodine—Nervous system disorder—Zoledronate—osteoporosis	0.000629	0.00158	CcSEcCtD
Fesoterodine—Mediastinal disorder—Estradiol—osteoporosis	0.000627	0.00158	CcSEcCtD
Fesoterodine—Tachycardia—Zoledronate—osteoporosis	0.000626	0.00158	CcSEcCtD
Fesoterodine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000624	0.00157	CcSEcCtD
Fesoterodine—Somnolence—Pamidronate—osteoporosis	0.000624	0.00157	CcSEcCtD
Fesoterodine—Skin disorder—Zoledronate—osteoporosis	0.000623	0.00157	CcSEcCtD
Fesoterodine—Pruritus—Calcitriol—osteoporosis	0.000621	0.00156	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000619	0.00156	CcSEcCtD
Fesoterodine—Diarrhoea—Raloxifene—osteoporosis	0.000619	0.00156	CcSEcCtD
Fesoterodine—Dyspepsia—Pamidronate—osteoporosis	0.000618	0.00156	CcSEcCtD
Fesoterodine—Dizziness—Estropipate—osteoporosis	0.000618	0.00156	CcSEcCtD
Fesoterodine—Infection—Conjugated Estrogens—osteoporosis	0.000613	0.00154	CcSEcCtD
Fesoterodine—Diarrhoea—Ibandronate—osteoporosis	0.000613	0.00154	CcSEcCtD
Fesoterodine—Mental disorder—Estradiol—osteoporosis	0.000609	0.00153	CcSEcCtD
Fesoterodine—Dizziness—Alendronate—osteoporosis	0.000609	0.00153	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000606	0.00153	CcSEcCtD
Fesoterodine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000606	0.00152	CcSEcCtD
Fesoterodine—Fatigue—Pamidronate—osteoporosis	0.000605	0.00152	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Risedronate—osteoporosis	0.000604	0.00152	CcSEcCtD
Fesoterodine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000603	0.00152	CcSEcCtD
Fesoterodine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000602	0.00151	CcSEcCtD
Fesoterodine—Constipation—Pamidronate—osteoporosis	0.0006	0.00151	CcSEcCtD
Fesoterodine—Diarrhoea—Calcitriol—osteoporosis	0.0006	0.00151	CcSEcCtD
Fesoterodine—Skin disorder—Conjugated Estrogens—osteoporosis	0.0006	0.00151	CcSEcCtD
Fesoterodine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000599	0.00151	CcSEcCtD
Fesoterodine—Dizziness—Raloxifene—osteoporosis	0.000599	0.00151	CcSEcCtD
Fesoterodine—Flatulence—Estradiol—osteoporosis	0.000597	0.0015	CcSEcCtD
Fesoterodine—Dysgeusia—Estradiol—osteoporosis	0.000593	0.00149	CcSEcCtD
Fesoterodine—Dizziness—Ibandronate—osteoporosis	0.000593	0.00149	CcSEcCtD
Fesoterodine—Rash—Estropipate—osteoporosis	0.000589	0.00148	CcSEcCtD
Fesoterodine—Dermatitis—Estropipate—osteoporosis	0.000589	0.00148	CcSEcCtD
Fesoterodine—Urticaria—Risedronate—osteoporosis	0.000587	0.00148	CcSEcCtD
Fesoterodine—Back pain—Estradiol—osteoporosis	0.000586	0.00147	CcSEcCtD
Fesoterodine—Headache—Estropipate—osteoporosis	0.000585	0.00147	CcSEcCtD
Fesoterodine—Abdominal pain—Risedronate—osteoporosis	0.000584	0.00147	CcSEcCtD
Fesoterodine—Rash—Alendronate—osteoporosis	0.00058	0.00146	CcSEcCtD
Fesoterodine—Insomnia—Zoledronate—osteoporosis	0.00058	0.00146	CcSEcCtD
Fesoterodine—Dermatitis—Alendronate—osteoporosis	0.00058	0.00146	CcSEcCtD
Fesoterodine—Feeling abnormal—Pamidronate—osteoporosis	0.000579	0.00146	CcSEcCtD
Fesoterodine—Headache—Alendronate—osteoporosis	0.000577	0.00145	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000574	0.00144	CcSEcCtD
Fesoterodine—Rash—Raloxifene—osteoporosis	0.000571	0.00144	CcSEcCtD
Fesoterodine—Dermatitis—Raloxifene—osteoporosis	0.00057	0.00144	CcSEcCtD
Fesoterodine—Somnolence—Zoledronate—osteoporosis	0.00057	0.00143	CcSEcCtD
Fesoterodine—Headache—Raloxifene—osteoporosis	0.000567	0.00143	CcSEcCtD
Fesoterodine—Rash—Ibandronate—osteoporosis	0.000565	0.00142	CcSEcCtD
Fesoterodine—Dermatitis—Ibandronate—osteoporosis	0.000565	0.00142	CcSEcCtD
Fesoterodine—Dyspepsia—Zoledronate—osteoporosis	0.000565	0.00142	CcSEcCtD
Fesoterodine—Headache—Ibandronate—osteoporosis	0.000561	0.00141	CcSEcCtD
Fesoterodine—Insomnia—Conjugated Estrogens—osteoporosis	0.000559	0.00141	CcSEcCtD
Fesoterodine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000558	0.0014	CcSEcCtD
Fesoterodine—Nausea—Estropipate—osteoporosis	0.000555	0.0014	CcSEcCtD
Fesoterodine—Abdominal pain—Pamidronate—osteoporosis	0.000555	0.0014	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000554	0.00139	CcSEcCtD
Fesoterodine—Angioedema—Estradiol—osteoporosis	0.000553	0.00139	CcSEcCtD
Fesoterodine—Rash—Calcitriol—osteoporosis	0.000553	0.00139	CcSEcCtD
Fesoterodine—Fatigue—Zoledronate—osteoporosis	0.000553	0.00139	CcSEcCtD
Fesoterodine—Dermatitis—Calcitriol—osteoporosis	0.000553	0.00139	CcSEcCtD
Fesoterodine—Headache—Calcitriol—osteoporosis	0.00055	0.00138	CcSEcCtD
Fesoterodine—Somnolence—Conjugated Estrogens—osteoporosis	0.000549	0.00138	CcSEcCtD
Fesoterodine—Constipation—Zoledronate—osteoporosis	0.000548	0.00138	CcSEcCtD
Fesoterodine—Nausea—Alendronate—osteoporosis	0.000547	0.00138	CcSEcCtD
Fesoterodine—Hypersensitivity—Risedronate—osteoporosis	0.000544	0.00137	CcSEcCtD
Fesoterodine—Vertigo—Estradiol—osteoporosis	0.000544	0.00137	CcSEcCtD
Fesoterodine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000544	0.00137	CcSEcCtD
Fesoterodine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000543	0.00137	CcSEcCtD
Fesoterodine—Nausea—Raloxifene—osteoporosis	0.000538	0.00135	CcSEcCtD
Fesoterodine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000536	0.00135	CcSEcCtD
Fesoterodine—Palpitations—Estradiol—osteoporosis	0.000535	0.00135	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000533	0.00134	CcSEcCtD
Fesoterodine—Fatigue—Conjugated Estrogens—osteoporosis	0.000532	0.00134	CcSEcCtD
Fesoterodine—Nausea—Ibandronate—osteoporosis	0.000532	0.00134	CcSEcCtD
Fesoterodine—Asthenia—Risedronate—osteoporosis	0.00053	0.00133	CcSEcCtD
Fesoterodine—Feeling abnormal—Zoledronate—osteoporosis	0.000528	0.00133	CcSEcCtD
Fesoterodine—Cough—Estradiol—osteoporosis	0.000528	0.00133	CcSEcCtD
Fesoterodine—Constipation—Conjugated Estrogens—osteoporosis	0.000528	0.00133	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000524	0.00132	CcSEcCtD
Fesoterodine—Pruritus—Risedronate—osteoporosis	0.000523	0.00132	CcSEcCtD
Fesoterodine—Nausea—Calcitriol—osteoporosis	0.000521	0.00131	CcSEcCtD
Fesoterodine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000518	0.0013	CcSEcCtD
Fesoterodine—Hypersensitivity—Pamidronate—osteoporosis	0.000517	0.0013	CcSEcCtD
Fesoterodine—Chest pain—Estradiol—osteoporosis	0.000516	0.0013	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000512	0.00129	CcSEcCtD
Fesoterodine—Urticaria—Zoledronate—osteoporosis	0.000509	0.00128	CcSEcCtD
Fesoterodine—Abdominal pain—Zoledronate—osteoporosis	0.000507	0.00128	CcSEcCtD
Fesoterodine—Diarrhoea—Risedronate—osteoporosis	0.000505	0.00127	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000505	0.00127	CcSEcCtD
Fesoterodine—Dry mouth—Estradiol—osteoporosis	0.000504	0.00127	CcSEcCtD
Fesoterodine—Asthenia—Pamidronate—osteoporosis	0.000504	0.00127	CcSEcCtD
Fesoterodine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000501	0.00126	CcSEcCtD
Fesoterodine—Confusional state—Estradiol—osteoporosis	0.000498	0.00125	CcSEcCtD
Fesoterodine—Pruritus—Pamidronate—osteoporosis	0.000497	0.00125	CcSEcCtD
Fesoterodine—Infection—Estradiol—osteoporosis	0.000491	0.00124	CcSEcCtD
Fesoterodine—Urticaria—Conjugated Estrogens—osteoporosis	0.000491	0.00123	CcSEcCtD
Fesoterodine—Dizziness—Risedronate—osteoporosis	0.000488	0.00123	CcSEcCtD
Fesoterodine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000488	0.00123	CcSEcCtD
Fesoterodine—Nervous system disorder—Estradiol—osteoporosis	0.000485	0.00122	CcSEcCtD
Fesoterodine—Tachycardia—Estradiol—osteoporosis	0.000482	0.00121	CcSEcCtD
Fesoterodine—Diarrhoea—Pamidronate—osteoporosis	0.00048	0.00121	CcSEcCtD
Fesoterodine—Skin disorder—Estradiol—osteoporosis	0.00048	0.00121	CcSEcCtD
Fesoterodine—Rash—Ethinyl Estradiol—osteoporosis	0.000478	0.0012	CcSEcCtD
Fesoterodine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000477	0.0012	CcSEcCtD
Fesoterodine—Headache—Ethinyl Estradiol—osteoporosis	0.000475	0.00119	CcSEcCtD
Fesoterodine—Hypersensitivity—Zoledronate—osteoporosis	0.000472	0.00119	CcSEcCtD
Fesoterodine—Rash—Risedronate—osteoporosis	0.000466	0.00117	CcSEcCtD
Fesoterodine—Dermatitis—Risedronate—osteoporosis	0.000465	0.00117	CcSEcCtD
Fesoterodine—Dizziness—Pamidronate—osteoporosis	0.000464	0.00117	CcSEcCtD
Fesoterodine—Headache—Risedronate—osteoporosis	0.000463	0.00116	CcSEcCtD
Fesoterodine—Asthenia—Zoledronate—osteoporosis	0.00046	0.00116	CcSEcCtD
Fesoterodine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000455	0.00115	CcSEcCtD
Fesoterodine—Pruritus—Zoledronate—osteoporosis	0.000454	0.00114	CcSEcCtD
Fesoterodine—Nausea—Ethinyl Estradiol—osteoporosis	0.00045	0.00113	CcSEcCtD
Fesoterodine—Insomnia—Estradiol—osteoporosis	0.000447	0.00113	CcSEcCtD
Fesoterodine—Asthenia—Conjugated Estrogens—osteoporosis	0.000443	0.00112	CcSEcCtD
Fesoterodine—Rash—Pamidronate—osteoporosis	0.000443	0.00111	CcSEcCtD
Fesoterodine—Dermatitis—Pamidronate—osteoporosis	0.000442	0.00111	CcSEcCtD
Fesoterodine—Headache—Pamidronate—osteoporosis	0.00044	0.00111	CcSEcCtD
Fesoterodine—Somnolence—Estradiol—osteoporosis	0.000439	0.00111	CcSEcCtD
Fesoterodine—Diarrhoea—Zoledronate—osteoporosis	0.000439	0.0011	CcSEcCtD
Fesoterodine—Nausea—Risedronate—osteoporosis	0.000439	0.0011	CcSEcCtD
Fesoterodine—Pruritus—Conjugated Estrogens—osteoporosis	0.000437	0.0011	CcSEcCtD
Fesoterodine—Dyspepsia—Estradiol—osteoporosis	0.000435	0.00109	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000427	0.00107	CcSEcCtD
Fesoterodine—Fatigue—Estradiol—osteoporosis	0.000426	0.00107	CcSEcCtD
Fesoterodine—Dizziness—Zoledronate—osteoporosis	0.000424	0.00107	CcSEcCtD
Fesoterodine—Constipation—Estradiol—osteoporosis	0.000423	0.00106	CcSEcCtD
Fesoterodine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000423	0.00106	CcSEcCtD
Fesoterodine—Nausea—Pamidronate—osteoporosis	0.000417	0.00105	CcSEcCtD
Fesoterodine—Dizziness—Conjugated Estrogens—osteoporosis	0.000408	0.00103	CcSEcCtD
Fesoterodine—Feeling abnormal—Estradiol—osteoporosis	0.000407	0.00103	CcSEcCtD
Fesoterodine—Rash—Zoledronate—osteoporosis	0.000404	0.00102	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Estradiol—osteoporosis	0.000404	0.00102	CcSEcCtD
Fesoterodine—Dermatitis—Zoledronate—osteoporosis	0.000404	0.00102	CcSEcCtD
Fesoterodine—Headache—Zoledronate—osteoporosis	0.000402	0.00101	CcSEcCtD
Fesoterodine—Urticaria—Estradiol—osteoporosis	0.000393	0.000988	CcSEcCtD
Fesoterodine—Abdominal pain—Estradiol—osteoporosis	0.000391	0.000983	CcSEcCtD
Fesoterodine—Rash—Conjugated Estrogens—osteoporosis	0.000389	0.00098	CcSEcCtD
Fesoterodine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000389	0.000979	CcSEcCtD
Fesoterodine—Headache—Conjugated Estrogens—osteoporosis	0.000387	0.000974	CcSEcCtD
Fesoterodine—Nausea—Zoledronate—osteoporosis	0.000381	0.000959	CcSEcCtD
Fesoterodine—Nausea—Conjugated Estrogens—osteoporosis	0.000367	0.000923	CcSEcCtD
Fesoterodine—Hypersensitivity—Estradiol—osteoporosis	0.000364	0.000916	CcSEcCtD
Fesoterodine—Asthenia—Estradiol—osteoporosis	0.000355	0.000892	CcSEcCtD
Fesoterodine—Pruritus—Estradiol—osteoporosis	0.00035	0.00088	CcSEcCtD
Fesoterodine—Diarrhoea—Estradiol—osteoporosis	0.000338	0.000851	CcSEcCtD
Fesoterodine—Dizziness—Estradiol—osteoporosis	0.000327	0.000823	CcSEcCtD
Fesoterodine—Rash—Estradiol—osteoporosis	0.000312	0.000784	CcSEcCtD
Fesoterodine—Dermatitis—Estradiol—osteoporosis	0.000311	0.000784	CcSEcCtD
Fesoterodine—Headache—Estradiol—osteoporosis	0.00031	0.000779	CcSEcCtD
Fesoterodine—Nausea—Estradiol—osteoporosis	0.000294	0.000739	CcSEcCtD
Fesoterodine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	3.89e-05	0.000915	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—ADCY5—osteoporosis	3.88e-05	0.000912	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—NFATC1—osteoporosis	3.84e-05	0.000904	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—CALCA—osteoporosis	3.84e-05	0.000903	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—WNT1—osteoporosis	3.84e-05	0.000902	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—CALCA—osteoporosis	3.83e-05	0.0009	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—DKK1—osteoporosis	3.81e-05	0.000897	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—CALCA—osteoporosis	3.79e-05	0.000891	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—FGA—osteoporosis	3.73e-05	0.000877	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—TPI1—osteoporosis	3.68e-05	0.000865	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—ADCY5—osteoporosis	3.68e-05	0.000865	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—WNT1—osteoporosis	3.67e-05	0.000864	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ATIC—osteoporosis	3.67e-05	0.000864	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PNP—osteoporosis	3.67e-05	0.000864	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—FGA—osteoporosis	3.57e-05	0.00084	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—POMC—osteoporosis	3.55e-05	0.000836	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—POMC—osteoporosis	3.54e-05	0.000833	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—ADCY5—osteoporosis	3.52e-05	0.000828	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—POMC—osteoporosis	3.51e-05	0.000825	CbGpPWpGaD
Fesoterodine—CHRM2—SIDS Susceptibility Pathways—IL6—osteoporosis	3.49e-05	0.000822	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—CALCA—osteoporosis	3.49e-05	0.00082	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—CALCA—osteoporosis	3.47e-05	0.000817	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—PTHLH—osteoporosis	3.47e-05	0.000816	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—BMP2—osteoporosis	3.47e-05	0.000816	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—P4HB—osteoporosis	3.46e-05	0.000813	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—CALCA—osteoporosis	3.44e-05	0.000809	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—GAPDH—osteoporosis	3.4e-05	0.000798	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—FGB—osteoporosis	3.39e-05	0.000798	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TLN1—osteoporosis	3.36e-05	0.000791	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TLN1—osteoporosis	3.35e-05	0.000789	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—PTHLH—osteoporosis	3.32e-05	0.000781	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—BMP2—osteoporosis	3.32e-05	0.000781	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TLN1—osteoporosis	3.32e-05	0.000781	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CA2—osteoporosis	3.31e-05	0.000779	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—OXCT1—osteoporosis	3.31e-05	0.000779	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—RAP1A—osteoporosis	3.31e-05	0.000778	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—PSMA5—osteoporosis	3.28e-05	0.000771	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—PSMA2—osteoporosis	3.28e-05	0.000771	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—FGB—osteoporosis	3.25e-05	0.000764	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—MGLL—osteoporosis	3.23e-05	0.000759	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—PSMA2—osteoporosis	3.14e-05	0.000738	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—PSMA5—osteoporosis	3.14e-05	0.000738	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—OXCT1—osteoporosis	3.12e-05	0.000734	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CA2—osteoporosis	3.12e-05	0.000734	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CALCA—osteoporosis	3.05e-05	0.000718	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—MGLL—osteoporosis	3.04e-05	0.000716	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—POMC—osteoporosis	2.98e-05	0.0007	CbGpPWpGaD
Fesoterodine—CYP3A4—Biological oxidations—POMC—osteoporosis	2.94e-05	0.00069	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CALCA—osteoporosis	2.92e-05	0.000688	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—P4HB—osteoporosis	2.9e-05	0.000682	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—P4HB—osteoporosis	2.89e-05	0.00068	CbGpPWpGaD
Fesoterodine—CHRM1—Circadian rythm related genes—IL6—osteoporosis	2.89e-05	0.00068	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—P4HB—osteoporosis	2.86e-05	0.000674	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—POMC—osteoporosis	2.85e-05	0.000671	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PTH—osteoporosis	2.82e-05	0.000664	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PTH—osteoporosis	2.81e-05	0.000662	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PTH—osteoporosis	2.79e-05	0.000655	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—RAP1A—osteoporosis	2.77e-05	0.000652	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—KL—osteoporosis	2.77e-05	0.000652	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PKM—osteoporosis	2.77e-05	0.000651	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—FDPS—osteoporosis	2.77e-05	0.000651	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—RAP1A—osteoporosis	2.76e-05	0.00065	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CNR2—osteoporosis	2.75e-05	0.000647	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—IDH2—osteoporosis	2.75e-05	0.000646	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CNR2—osteoporosis	2.74e-05	0.000645	CbGpPWpGaD
Fesoterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	2.74e-05	0.000644	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—RAP1A—osteoporosis	2.74e-05	0.000644	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—ADCY5—osteoporosis	2.73e-05	0.000642	CbGpPWpGaD
Fesoterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	2.73e-05	0.000642	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—ADCY5—osteoporosis	2.72e-05	0.00064	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CNR2—osteoporosis	2.72e-05	0.000639	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NFATC1—osteoporosis	2.71e-05	0.000636	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—POMC—osteoporosis	2.7e-05	0.000636	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NFATC1—osteoporosis	2.7e-05	0.000634	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—ADCY5—osteoporosis	2.7e-05	0.000634	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—DKK1—osteoporosis	2.68e-05	0.000631	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—DKK1—osteoporosis	2.68e-05	0.000629	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—ENO1—osteoporosis	2.67e-05	0.000629	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NFATC1—osteoporosis	2.67e-05	0.000628	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—KL—osteoporosis	2.66e-05	0.000624	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—DKK1—osteoporosis	2.65e-05	0.000623	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—IL6R—osteoporosis	2.64e-05	0.00062	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PSMA2—osteoporosis	2.63e-05	0.000619	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PSMA5—osteoporosis	2.63e-05	0.000619	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PGLS—osteoporosis	2.62e-05	0.000617	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GPD2—osteoporosis	2.62e-05	0.000617	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—POMC—osteoporosis	2.59e-05	0.000609	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—IDH2—osteoporosis	2.59e-05	0.000608	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—WNT1—osteoporosis	2.59e-05	0.000608	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CYP27A1—osteoporosis	2.58e-05	0.000607	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—WNT1—osteoporosis	2.58e-05	0.000606	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—WNT1—osteoporosis	2.55e-05	0.0006	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	2.53e-05	0.000596	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	2.53e-05	0.000594	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—IL6R—osteoporosis	2.53e-05	0.000594	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—FGA—osteoporosis	2.52e-05	0.000592	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ACP5—osteoporosis	2.51e-05	0.00059	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—FGA—osteoporosis	2.51e-05	0.00059	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—FGA—osteoporosis	2.48e-05	0.000584	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—ADCY5—osteoporosis	2.48e-05	0.000583	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—ADCY5—osteoporosis	2.47e-05	0.000581	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—ADCY5—osteoporosis	2.45e-05	0.000576	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CYP27A1—osteoporosis	2.43e-05	0.000572	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ATIC—osteoporosis	2.4e-05	0.000565	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PNP—osteoporosis	2.4e-05	0.000565	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ACP5—osteoporosis	2.37e-05	0.000556	CbGpPWpGaD
Fesoterodine—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.37e-05	0.000556	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.36e-05	0.000555	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PTHLH—osteoporosis	2.34e-05	0.00055	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—BMP2—osteoporosis	2.34e-05	0.00055	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—TPI1—osteoporosis	2.33e-05	0.000549	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PTHLH—osteoporosis	2.33e-05	0.000548	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—BMP2—osteoporosis	2.33e-05	0.000548	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PTHLH—osteoporosis	2.31e-05	0.000543	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—BMP2—osteoporosis	2.31e-05	0.000543	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—FGB—osteoporosis	2.29e-05	0.000538	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—FGB—osteoporosis	2.28e-05	0.000537	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—FGB—osteoporosis	2.26e-05	0.000531	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PSMA2—osteoporosis	2.21e-05	0.00052	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PSMA5—osteoporosis	2.21e-05	0.00052	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PSMA5—osteoporosis	2.2e-05	0.000518	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PSMA2—osteoporosis	2.2e-05	0.000518	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—TPI1—osteoporosis	2.2e-05	0.000517	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—P4HB—osteoporosis	2.19e-05	0.000516	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PSMA2—osteoporosis	2.18e-05	0.000513	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PSMA5—osteoporosis	2.18e-05	0.000513	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—ADCY5—osteoporosis	2.17e-05	0.000511	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GAPDH—osteoporosis	2.15e-05	0.000507	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CYP19A1—osteoporosis	2.14e-05	0.000503	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—SPP1—osteoporosis	2.1e-05	0.000494	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—RAP1A—osteoporosis	2.1e-05	0.000493	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—ADCY5—osteoporosis	2.08e-05	0.000489	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—P4HB—osteoporosis	2.07e-05	0.000486	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CALCA—osteoporosis	2.06e-05	0.000484	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CALCA—osteoporosis	2.05e-05	0.000483	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CA2—osteoporosis	2.04e-05	0.00048	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—OXCT1—osteoporosis	2.04e-05	0.00048	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CALCA—osteoporosis	2.03e-05	0.000478	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GAPDH—osteoporosis	2.03e-05	0.000477	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—SPP1—osteoporosis	2.01e-05	0.000473	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—POMC—osteoporosis	2.01e-05	0.000472	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—POMC—osteoporosis	2e-05	0.000471	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—MGLL—osteoporosis	1.99e-05	0.000468	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—POMC—osteoporosis	1.98e-05	0.000466	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—RAP1A—osteoporosis	1.98e-05	0.000465	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IRS2—osteoporosis	1.9e-05	0.000447	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—KL—osteoporosis	1.87e-05	0.00044	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—KL—osteoporosis	1.86e-05	0.000438	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—LEP—osteoporosis	1.86e-05	0.000437	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—KL—osteoporosis	1.85e-05	0.000434	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—POMC—osteoporosis	1.82e-05	0.000429	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IRS2—osteoporosis	1.82e-05	0.000428	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—POMC—osteoporosis	1.82e-05	0.000427	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—POMC—osteoporosis	1.8e-05	0.000423	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—LEP—osteoporosis	1.78e-05	0.000419	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—IL6R—osteoporosis	1.78e-05	0.000418	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—ESR1—osteoporosis	1.78e-05	0.000418	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—IL6R—osteoporosis	1.77e-05	0.000417	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—IL6R—osteoporosis	1.76e-05	0.000413	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—ADCY5—osteoporosis	1.75e-05	0.000411	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—GPX1—osteoporosis	1.74e-05	0.000409	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—ESR1—osteoporosis	1.7e-05	0.0004	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ENO1—osteoporosis	1.7e-05	0.000399	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—IDH2—osteoporosis	1.69e-05	0.000398	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PSMA5—osteoporosis	1.67e-05	0.000393	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PSMA2—osteoporosis	1.67e-05	0.000393	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IRS1—osteoporosis	1.66e-05	0.00039	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—MTHFR—osteoporosis	1.61e-05	0.000378	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ENO1—osteoporosis	1.6e-05	0.000376	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—POMC—osteoporosis	1.6e-05	0.000376	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.59e-05	0.000374	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IRS1—osteoporosis	1.59e-05	0.000374	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PSMA2—osteoporosis	1.57e-05	0.00037	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PSMA5—osteoporosis	1.57e-05	0.00037	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IL6R—osteoporosis	1.56e-05	0.000367	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ACP5—osteoporosis	1.55e-05	0.000364	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IGF1—osteoporosis	1.54e-05	0.000361	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—POMC—osteoporosis	1.53e-05	0.00036	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IL6R—osteoporosis	1.49e-05	0.000351	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IGF1—osteoporosis	1.47e-05	0.000346	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—ADCY5—osteoporosis	1.46e-05	0.000344	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—ADCY5—osteoporosis	1.46e-05	0.000343	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—ADCY5—osteoporosis	1.45e-05	0.00034	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—TPI1—osteoporosis	1.44e-05	0.000338	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—SPP1—osteoporosis	1.42e-05	0.000333	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—SPP1—osteoporosis	1.41e-05	0.000332	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—SPP1—osteoporosis	1.4e-05	0.000329	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CYP19A1—osteoporosis	1.36e-05	0.000319	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—P4HB—osteoporosis	1.35e-05	0.000318	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GAPDH—osteoporosis	1.33e-05	0.000312	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—RAP1A—osteoporosis	1.29e-05	0.000304	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—POMC—osteoporosis	1.28e-05	0.000302	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IRS2—osteoporosis	1.28e-05	0.000301	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.28e-05	0.0003	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IRS2—osteoporosis	1.28e-05	0.0003	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IRS2—osteoporosis	1.26e-05	0.000297	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—LEP—osteoporosis	1.25e-05	0.000295	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—LEP—osteoporosis	1.25e-05	0.000294	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—LEP—osteoporosis	1.24e-05	0.000291	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—ESR1—osteoporosis	1.2e-05	0.000282	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—ESR1—osteoporosis	1.19e-05	0.000281	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—ESR1—osteoporosis	1.18e-05	0.000278	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—IL6—osteoporosis	1.18e-05	0.000276	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—IL6—osteoporosis	1.13e-05	0.000265	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IRS1—osteoporosis	1.12e-05	0.000263	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IRS1—osteoporosis	1.12e-05	0.000262	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ADCY5—osteoporosis	1.11e-05	0.000261	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IRS1—osteoporosis	1.1e-05	0.00026	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GPX1—osteoporosis	1.1e-05	0.00026	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—POMC—osteoporosis	1.08e-05	0.000253	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—POMC—osteoporosis	1.07e-05	0.000253	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—POMC—osteoporosis	1.06e-05	0.00025	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IL6R—osteoporosis	1.05e-05	0.000247	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IL6R—osteoporosis	1.05e-05	0.000246	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ENO1—osteoporosis	1.04e-05	0.000246	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ADCY5—osteoporosis	1.04e-05	0.000246	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GPX1—osteoporosis	1.04e-05	0.000245	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IL6R—osteoporosis	1.04e-05	0.000244	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IGF1—osteoporosis	1.04e-05	0.000244	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IGF1—osteoporosis	1.03e-05	0.000243	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PSMA2—osteoporosis	1.03e-05	0.000242	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PSMA5—osteoporosis	1.03e-05	0.000242	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IGF1—osteoporosis	1.02e-05	0.000241	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—MTHFR—osteoporosis	1.02e-05	0.00024	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—MTHFR—osteoporosis	9.6e-06	0.000226	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MYC—osteoporosis	9.24e-06	0.000217	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TGFB1—osteoporosis	9.21e-06	0.000217	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MYC—osteoporosis	8.84e-06	0.000208	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TGFB1—osteoporosis	8.82e-06	0.000207	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP19A1—osteoporosis	8.35e-06	0.000196	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—POMC—osteoporosis	8.15e-06	0.000192	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—IL6—osteoporosis	7.92e-06	0.000186	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—IL6—osteoporosis	7.9e-06	0.000186	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—IL6—osteoporosis	7.82e-06	0.000184	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—POMC—osteoporosis	7.68e-06	0.000181	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IL6—osteoporosis	6.94e-06	0.000163	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ADCY5—osteoporosis	6.83e-06	0.000161	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GPX1—osteoporosis	6.8e-06	0.00016	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IL6—osteoporosis	6.65e-06	0.000156	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—MTHFR—osteoporosis	6.28e-06	0.000148	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MYC—osteoporosis	6.23e-06	0.000146	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TGFB1—osteoporosis	6.21e-06	0.000146	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MYC—osteoporosis	6.21e-06	0.000146	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TGFB1—osteoporosis	6.19e-06	0.000146	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MYC—osteoporosis	6.15e-06	0.000145	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TGFB1—osteoporosis	6.13e-06	0.000144	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—POMC—osteoporosis	5.02e-06	0.000118	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IL6—osteoporosis	4.68e-06	0.00011	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IL6—osteoporosis	4.67e-06	0.00011	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IL6—osteoporosis	4.62e-06	0.000109	CbGpPWpGaD
